Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$653M |
| 2 |
Amazon
AMZN
|
+$602M |
| 3 |
ExxonMobil
XOM
|
+$473M |
| 4 |
Tesla
TSLA
|
+$437M |
| 5 |
Starbucks
SBUX
|
+$380M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$511M |
| 2 |
Netflix
NFLX
|
+$427M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$397M |
| 4 |
Nike
NKE
|
+$373M |
| 5 |
Microsoft
MSFT
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.68% |
| 2 | Healthcare | 17.69% |
| 3 | Consumer Discretionary | 13.09% |
| 4 | Industrials | 7.96% |
| 5 | Consumer Staples | 7.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1626
CNA Financial
CNA
$14.3B
| $3.28M | 0.01% |
77,500
+44,000
| +131% | +$1.79M |
|
|
PENG
1627
Penguin Solutions Inc
PENG
$2.96B
| $3.26M | 0.01% |
172,372
-149,900
| -47% | -$2.59M |
|
1628
Global Water Resources
GWRS
$211M
| $3.26M | 0.01% |
249,051
-31,096
| -11% | -$350K |
|
1629
Universal Display
OLED
$3.96B
| $3.25M | 0.01% |
17,000
-71,600
| -81% | -$11.8M |
|
1630
Xeris Biopharma Holdings
XERS
$1.41B
| $3.25M | 0.01% |
1,381,640
+359,600
| +35% | +$664K |
|
1631
Gildan
GIL
$10.5B
| $3.24M | 0.01% |
97,900
+49,500
| +102% | +$1.6M |
|
1632
Invesco FTSE RAFI US 1000 ETF
PRF
$10B
| $3.24M | 0.01% |
92,100
+51,500
| +127% | +$1.69M |
|
|
ORTX
1633
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $3.24M | 0.01% |
196,918
+82,100
| +72% | +$1.29M |
|
1634
iShares Currency Hedged MSCI EAFE ETF
HEFA
$7.64B
| $3.24M | 0.01% |
102,700
+77,300
| +304% | +$2.36M |
|
1635
Hyster-Yale Materials Handling
HY
$629M
| $3.23M | 0.01% |
51,885
+13,785
| +36% | +$657K |
|
1636
Gulfport Energy Corp
GPOR
$2.8B
| $3.22M | 0.01% |
24,200
-19,000
| -44% | -$2.45M |
|
1637
Materion
MTRN
$4.72B
| $3.21M | 0.01% |
24,707
-18,999
| -43% | -$2.08M |
|
1638
Paymentus
PAY
$5.61B
| $3.21M | 0.01% |
179,800
+36,368
| +25% | +$594K |
|
1639
Invesco Preferred ETF
PGX
$3.81B
| $3.21M | 0.01% |
+279,800
| New | +$3.05M |
|
1640
Designer Brands
DBI
$336M
| $3.2M | 0.01% |
+361,930
| New | +$3.81M |
|
1641
Heron Therapeutics
HRTX
$96.8M
| $3.2M | 0.01% |
1,883,300
+1,592,000
| +547% | +$1.75M |
|
1642
Invesco NASDAQ 100 ETF
QQQM
$102B
| $3.2M | 0.01% |
+19,000
| New | +$2.97M |
|
1643
Capital Group Growth ETF
CGGR
$25.1B
| $3.2M | ﹤0.01% |
113,300
+75,700
| +201% | +$1.96M |
|
|
SKX
1644
DELISTED
Skechers
SKX
| $3.2M | ﹤0.01% |
51,300
-156,600
| -75% | -$8.44M |
|
1645
Ecovyst
ECVT
$1.33B
| $3.19M | ﹤0.01% |
326,100
-43,600
| -12% | -$415K |
|
1646
Mesa Laboratories
MLAB
$566M
| $3.19M | ﹤0.01% |
30,400
+21,600
| +245% | +$2.1M |
|
1647
Vanguard Russell 1000 Value ETF
VONV
$21.1B
| $3.18M | ﹤0.01% |
43,800
+28,800
| +192% | +$1.95M |
|
|
ME
1648
DELISTED
23andMe Holding Co
ME
| $3.18M | ﹤0.01% |
173,903
+33,045
| +23% | +$571K |
|
1649
Leslie's
LESL
$12.4M
| $3.17M | ﹤0.01% |
+22,965
| New | +$2.53M |
|
1650
Open Text
OTEX
$6.41B
| $3.17M | ﹤0.01% |
75,100
+30,700
| +69% | +$1.15M |
|
Similar funds
Renaissance Technologies's Q4 2023 Portfolio in Review
As of Q4 2023, Renaissance Technologies held 4,318 positions worth $64.6B, up 10% from $58.7B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies's Q4 2023 filing shows 702 new, 1,590 increased, 1,355 reduced and 633 closed positions. Its largest new stake was Amazon: 4,296,466 shares worth $653M. The largest sale was Berkshire Hathaway Class A, an estimated $511M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Renaissance Technologies's largest Q4 2023 buy was Amazon: 4,296,466 shares worth $653M.
- Renaissance Technologies added most to Meta Platforms (Facebook) in Q4 2023, an estimated $653M increase.
- Renaissance Technologies's biggest Q4 2023 reduction was Berkshire Hathaway Class A, cutting an estimated $511M.
- Renaissance Technologies fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $397M.
- Renaissance Technologies's ten largest holdings make up 12% of its $64.6B portfolio in Q4 2023.
- Renaissance Technologies opened 702 new positions and closed 633 in Q4 2023.
- Renaissance Technologies's portfolio value rose 10% quarter-over-quarter to $64.6B.
Based on Renaissance Technologies's 13F filing for Q4 2023, filed 13 Feb 2024.